Pharming (PHAR) Current Assets (2019 - 2025)
Pharming's Current Assets history spans 7 years, with the latest figure at $299.5 million for Q4 2025.
- Quarterly results put Current Assets at $299.5 million for Q4 2025, up 7.55% from a year ago — trailing twelve months through Dec 2025 was $299.5 million (up 7.55% YoY), and the annual figure for FY2025 was $299.5 million, up 7.55%.
- Current Assets for Q4 2025 was $299.5 million at Pharming, up from $278.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $316.3 million in Q4 2023 to a low of $249.4 million in Q4 2021.
- The 5-year median for Current Assets is $278.4 million (2024), against an average of $284.2 million.
- The sharpest move saw Current Assets increased 14.0% in 2023, then fell 11.98% in 2024.
- Year by year, Current Assets stood at $249.4 million in 2021, then grew by 11.25% to $277.5 million in 2022, then grew by 14.0% to $316.3 million in 2023, then fell by 11.98% to $278.4 million in 2024, then grew by 7.55% to $299.5 million in 2025.
- According to Business Quant data, Current Assets over the past three periods came in at $299.5 million, $278.4 million, and $316.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.